China Optic Nerve Disorders Treatment Market Size & Outlook, 2026-2034

China Optic Nerve Disorders Treatment Market Insights

As per Reed Intelligence insights, the China Optic Nerve Disorders Treatment Market stood at USD 195.45 Million in 2025 and is anticipated to grow to USD 360.66 Million by 2034.
The China market is expected to advance at a CAGR of 7% from 2026 through 2034.
In 2025, Glaucoma-Associated Optic Neuropathy accounted for the highest share of the Disease Type market size.
During the forecast period, Optic Neuritis is set to register the highest growth, making it the most lucrative Disease Type segment.

Other Key Findings

In 2025, China represented 5.71% of the overall global Optic Nerve Disorders Treatment Market size.
United States is projected to lead the global Optic Nerve Disorders Treatment Market size by 2034.
Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
South Korea is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 62.52 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 195.45 Million
Market Size In 2034	USD 360.66 Million
Largest segment	Glaucoma-Associated Optic Neuropathy
Units	Revenue in USD Million
CAGR	7% (2026-2034)
Segmnetation Covered
Disease Type	Glaucoma-Associated Optic Neuropathy Optic Neuritis Ischemic Optic Neuropathy Traumatic Optic Neuropathy Other Optic Nerve Disorders
Treatment Type	Pharmaceutical Therapies Surgical Treatments Biologic Regenerative Therapies
End User	Hospitals Specialty Ophthalmology Clinics Ambulatory Surgical Centers
Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

China Optic Nerve Disorders Treatment Market Disease Type 2026-2034 (USD Million)

Disease Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Glaucoma-Associated Optic Neuropathy	XX.x	XX.x	XX.x	71.32	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Optic Neuritis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ischemic Optic Neuropathy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Traumatic Optic Neuropathy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Other Optic Nerve Disorders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Optic Nerve Disorders Treatment Market Treatment Type 2026-2034 (USD Million)

Treatment Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceutical Therapies	XX.x	XX.x	XX.x	106.43	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Surgical Treatments	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biologic Regenerative Therapies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Optic Nerve Disorders Treatment Market End User 2026-2034 (USD Million)

End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	104.98	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Ophthalmology Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ambulatory Surgical Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Optic Nerve Disorders Treatment Market Distribution Channel 2026-2034 (USD Million)

Distribution Channel	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospital Pharmacies	XX.x	XX.x	XX.x	100.74	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Retail Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.